Prevalence in the european union in 2019 lurbinectedin?

What was lurbinectedin’s prevalence in the EU in 2019?

I don’t have enough information from the provided materials to state lurbinectedin’s prevalence in the European Union in 2019 (for example, how many patients were treated with it, or the condition prevalence it was used for). “Prevalence” could also mean either the number of people with the target disease in the EU or the number using lurbinectedin—those are different measures.

Prevalence of what, exactly, in 2019?

To answer precisely, you need one clarification:
- Do you mean disease prevalence (how common the cancer/condition lurbinectedin treats was in the EU in 2019)?
- Or do you mean treatment prevalence (how many EU patients received lurbinectedin in 2019)?

Quick way to proceed

If you tell me which meaning you intend (disease vs. treatment), and the specific disease/indication you care about, I can format the 2019 EU prevalence figures accordingly. Also share the unit you want (patients, percent of population, or EU count).